8 active trials 2 recruiting 6 Phase 3 1 disease areas
| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 2/3 | 1 | |
| Phase 3 | 5 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07019922 | A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety | Epileptic Encephalopathy | Recruiting | 2026-08-03 |
| NCT07010471 | A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and… | Developmental and Epileptic Encephalopathy 1 | Active, Not Recruiting | 2026-08-04 |
| NCT07287163 | Clinical Trial of Vormatrigine in Adult Patients With Epilepsy | Epilepsy, Tonic-Clonic | Enrolling by Invitation | 2026-08-03 |
| NCT07505004 | Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults… | Focal Epilepsy | Active, Not Recruiting | 2026-08-03 |
| NCT06087276 | Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of… | Essential Tremor | Active, Not Recruiting | 2026-07-16 |
| Phase 2/3 | ||||
| NCT05818553 | A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic… | SCN2A Encephalopathy | Active, Not Recruiting | 2026-01-29 |
| Phase 2 | ||||
| NCT06908356 | An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal… | Focal Onset Seizure | Recruiting | 2025-04-03 |
| Phase 1/2 | ||||
| NCT05737784 | A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A… | SCN2A-DEE | Active, Not Recruiting | 2026-08-03 |
Epilepsy (6)